» Articles » PMID: 25410660

Phosphorylation of HnRNP K by Cyclin-dependent Kinase 2 Controls Cytosolic Accumulation of TDP-43

Abstract

Cytosolic accumulation of TAR DNA binding protein 43 (TDP-43) is a major neuropathological feature of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). However, the mechanisms involved in TDP-43 accumulation remain largely unknown. Previously, we reported that inhibitors of cyclin-dependent kinases (CDKs) prevented cytosolic stress granule accumulation of TDP-43, correlating with depletion of heterogeneous ribonucleoprotein (hnRNP) K from stress granules. In the present study, we further investigated the relationship between TDP-43 and hnRNP K and their control by CDKs. Inhibition of CDK2 abrogated the accumulation of TDP-43 into stress granules. Phosphorylated CDK2 co-localized with accumulated TDP-43 and phosphorylated hnRNP K in stress granules. Inhibition of CDK2 phosphorylation blocked phosphorylation of hnRNP K, preventing its incorporation into stress granules. Due to interaction between hnRNP K with TDP-43, the loss of hnRNP K from stress granules prevented accumulation of TDP-43. Mutation of Ser216 and Ser284 phosphorylation sites on hnRNP K inhibited hnRNP K- and TDP-43-positive stress granule formation in transfected cells. The interaction between hnRNP K and TDP-43 was further confirmed by the loss of TDP-43 accumulation following siRNA-mediated inhibition of hnRNP K expression. A substantial decrease of CDK2 and hnRNP K expression in spinal cord motor neurons in ALS patients demonstrates a potential key role for these proteins in ALS and TDP-43 accumulation, indicating that further investigation of the association between hnRNP K and TDP-43 is warranted. Understanding how kinase activity modulates TDP-43 accumulation may provide new pharmacological targets for disease intervention.

Citing Articles

Microglial ferroptotic stress causes non-cell autonomous neuronal death.

Liddell J, Hilton J, Kysenius K, Billings J, Nikseresht S, McInnes L Mol Neurodegener. 2024; 19(1):14.

PMID: 38317225 PMC: 10840184. DOI: 10.1186/s13024-023-00691-8.


Heterogeneous nuclear ribonucleoprotein K promotes cap-independent translation initiation of retroviral mRNAs.

Fuentes Y, Olguin V, Lopez-Ulloa B, Mendonca D, Ramos H, Abdalla A Nucleic Acids Res. 2024; 52(5):2625-2647.

PMID: 38165048 PMC: 10954487. DOI: 10.1093/nar/gkad1221.


TDP-43 Epigenetic Facets and Their Neurodegenerative Implications.

Gimenez J, Spalloni A, Cappelli S, Ciaiola F, Orlando V, Buratti E Int J Mol Sci. 2023; 24(18).

PMID: 37762112 PMC: 10530927. DOI: 10.3390/ijms241813807.


Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape.

Sudhakaran M, Doseff A Int J Mol Sci. 2023; 24(6).

PMID: 36982162 PMC: 10049280. DOI: 10.3390/ijms24065086.


Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation.

Mucha B, Qie S, Bajpai S, Tarallo V, Diehl J, Tedeschi F Nat Commun. 2022; 13(1):6614.

PMID: 36329064 PMC: 9633729. DOI: 10.1038/s41467-022-34402-6.